Historique
Bulletin de Périodique
Journal of Psychoactive Drugs , Vol.44, n°5 - November-December 2012
Paru le :
01/11/2012
Année
2012
Page(s) :
351-445
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
• Results of a pilot study to reduce methamphetamine use and sexual risk behaviors among methamphetamine-using men who have sex with men (MSM) not currently in treatment. Zule W.A., Poulton W.E., Coomes C.M., Mansergh G., Charania M., Wechsberg W.M., et al., p. 351-358.
• Drugs and sexual behavior. Bruno A., Scimeca G., Marino A.G., Mento C., Micò U., Romeo V.M., et al., p. 359-364.
• Helium inhalation in adolescents: Characteristics of users and prevalence of use. Whitt A., Garland E.L., Howard M.O., p. 365-371.
• Developing the climate schools: Ecstasy module - A universal internet-based drug prevention program. Newton N.C., Teesson M., Newton K.L., p. 372-380.
• Mental health symptoms and their relationship to cannabis use in adolescents attending residential treatment. Albertella L., Norberg M.M., p. 381-389.
• Adolescents' experiences of a strengths-based treatment program for substance abuse. Harris N., Brazeau J.N., Clarkson A., Brownlee K., Rawana E.P., p. 390-397.
• Early intervention of intravenous KB220IV- Neuroadaptagen Amino-Acid Therapy (NAAT)™ Improves behavioral outcomes in a residential addiction treatment program: a pilot study. Miller M., Chen A.L.C., Stokes S.D., Silverman S., Bowirrat A., Manka M., et al., p. 398-409.
• Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner. Lyvers M., Meester M., p. 410-417.
• Neuroenhancement among German university students: Motives, expectations, and relationship with psychoactive lifestyle drugs. Eickenhorst P., Vitzthum K., Klapp B.F., Groneberg D., Mache S., p. 418-427.
• Racial and ethnic differences in reported criminal justice referral at treatment admission. Arfken C.L., Said M., Owens D., p. 428-433.
• A case of treating cathinone dependence and comorbid depression using bupropion. Lev-Ran S., p. 434-436.
• An examination of the Fagerström test for nicotine dependence among concurrent tobacco and khat users. Nakajima M., al'Absi M., Dokam A., Alsoofi M., Khalil N.S., p. 437-441.
• Results of a pilot study to reduce methamphetamine use and sexual risk behaviors among methamphetamine-using men who have sex with men (MSM) not currently in treatment. Zule W.A., Poulton W.E., Coomes C.M., Mansergh G., Charania M., Wechsberg W.M., et al., p. 351-358.
• Drugs and sexual behavior. Bruno A., Scimeca G., Marino A.G., Mento C., Micò U., Romeo V.M., et al., p. 359-364.
• Helium inhalation in adolescents: Characteristics of users and prevalence of use. Whitt A., Garland E.L., Howard M.O., p. 365-371.
• Developing the climate schools: Ecstasy module - A universal internet-based drug prevention program. Newton N.C., Teesson M., Newton K.L., p. 372-380.
• Mental health symptoms and their relationship to cannabis use in adolescents attending residential treatment. Albertella L., Norberg M.M., p. 381-389.
• Adolescents' experiences of a strengths-based treatment program for substance abuse. Harris N., Brazeau J.N., Clarkson A., Brownlee K., Rawana E.P., p. 390-397.
• Early intervention of intravenous KB220IV- Neuroadaptagen Amino-Acid Therapy (NAAT)™ Improves behavioral outcomes in a residential addiction treatment program: a pilot study. Miller M., Chen A.L.C., Stokes S.D., Silverman S., Bowirrat A., Manka M., et al., p. 398-409.
• Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner. Lyvers M., Meester M., p. 410-417.
• Neuroenhancement among German university students: Motives, expectations, and relationship with psychoactive lifestyle drugs. Eickenhorst P., Vitzthum K., Klapp B.F., Groneberg D., Mache S., p. 418-427.
• Racial and ethnic differences in reported criminal justice referral at treatment admission. Arfken C.L., Said M., Owens D., p. 428-433.
• A case of treating cathinone dependence and comorbid depression using bupropion. Lev-Ran S., p. 434-436.
• An examination of the Fagerström test for nicotine dependence among concurrent tobacco and khat users. Nakajima M., al'Absi M., Dokam A., Alsoofi M., Khalil N.S., p. 437-441.
Cote :
Abonnement
Dépouillements
Ajouter le résultat à votre sélection
A. WHITT ;
E. L. GARLAND ;
M. O. HOWARD
|
2012
Dans Journal of Psychoactive Drugs (Vol.44, n°5, November-December 2012) Article : Périodique
Dans Journal of Psychoactive Drugs (Vol.44, n°5, November-December 2012) Article : Périodique
Although helium-related fatalities and concerns about potentially harmful effects of helium use have increased in recent years, virtually nothing is known about the epidemiology of helium inhalation in adolescents. This exploratory investigation[...]
L. ALBERTELLA ;
M. M. NORBERG
|
2012
Dans Journal of Psychoactive Drugs (Vol.44, n°5, November-December 2012) Article : Périodique
Dans Journal of Psychoactive Drugs (Vol.44, n°5, November-December 2012) Article : Périodique
The present study examined mental health symptoms and their relationship to cannabis use and treatment outcomes in a sample of adolescents who received treatment for cannabis dependence through a residential substance use program. The sample inc[...]
M. LYVERS ;
M. MEESTER
|
2012
Dans Journal of Psychoactive Drugs (Vol.44, n°5, November-December 2012) Article : Périodique
Dans Journal of Psychoactive Drugs (Vol.44, n°5, November-December 2012) Article : Périodique
Psychedelic drugs have long been known to be capable of inducing mystical or transcendental experiences. However, given the common "recreational" nature of much present-day psychedelic use, with typical doses tending to be lower than those commo[...]
S. LEV-RAN
|
2012
Dans Journal of Psychoactive Drugs (Vol.44, n°5, November-December 2012) Article : Périodique
Dans Journal of Psychoactive Drugs (Vol.44, n°5, November-December 2012) Article : Périodique
Cathinone is a potent CNS stimulant found in khat leaves. Cathinone and synthetic cathinone-derivatives have become popular recreational drugs in recent years, commonly marketed as "legal highs." In addition to acute physical and psychiatric adv[...]